サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1392693

ヘルスケアナノテクノロジーの世界市場レポート 2024年

Healthcare Nanotechnology Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ヘルスケアナノテクノロジーの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

ヘルスケアナノテクノロジーの市場規模は近年急速に拡大しています。2023年の3,080億3,000万米ドルから2024年には3,518億2,000万米ドルへと、CAGR14.2％で成長します。実績期間の成長は、ナノ材料の進歩、ナノ医療研究、規制支援、研究開発投資、ナノ構造生体材料に起因します。

がん疾患の増加は、ヘルスケアナノテクノロジー市場の成長を促進すると予想されます。ナノテクノロジーは有望ながん治療法です。この医療研究分野の向上は、がんを含む多くの疾患に対するより良い個別化治療法の発見に利用できます。世界的に、がんの有病率は増加しています。例えば、2021年1月、米国国立医学図書館によると、米国では2021年に新たに189万8,160人のがん患者が発生し、60万8,570人が死亡すると予測されています。したがって、がん患者の増加がヘルスケアナノテクノロジー市場の成長を牽引しています。

糖尿病と肥満の増加がヘルスケアナノテクノロジー市場の成長を促進すると予測されます。糖尿病とは、血糖値が高すぎる場合に発症する状態を指し、肥満とは、肥満度が30以上の状態を指します。ヘルスケアナノテクノロジーは、糖尿病と肥満を管理するための標的ドラッグデリバリーと精密医療アプローチを提供し、副作用を最小限に抑えながら治療効果を向上させる。例えば、ベルギーに本部を置く糖尿病連盟である国際糖尿病連盟によると、2022年6月、糖尿病の有病率は世界で10.5％に増加し、半数以上（44.7％）の人々がまだ診断されていません。IDFの予測によると、2045年までに7億8,300万人の成人、つまり8人に1人が糖尿病になるといわれています。これは46％の増加であり、同時期の人口増加予測（20％）の2倍以上です。さらに、スイスに本部を置く世界保健機関（WHO）によると、2022年3月には、6億5,000万人の成人、3億4,000万人のティーンエイジャー、3,900万人の子供が肥満になると予想されます。WHOは、2025年までに1億6,700万人の大人と子供が過体重または肥満になると予測しています。したがって、糖尿病と肥満の増加がヘルスケアナノテクノロジー市場の成長を牽引しています。

2023年のヘルスケアナノテクノロジー市場で最大の地域は北米です。アジア太平洋は予測期間中に最も急成長する地域となる見込みです。ヘルスケアナノテクノロジー市場レポートの対象地域は、アジア太平洋,西欧,東欧,北米,南米,中東,アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 ヘルスケアナノテクノロジー市場の特徴

第3章 ヘルスケアナノテクノロジー市場の動向と戦略

第4章 ヘルスケアナノテクノロジー市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界のヘルスケアナノテクノロジー市場規模と成長

  • 世界のヘルスケアナノテクノロジー市場促進要因と制約要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界のヘルスケアナノテクノロジーの市場規模実績と成長、2018～2023年
  • 世界のヘルスケアナノテクノロジー市場規模と成長予測、2023年から2028年、2033F

第6章 ヘルスケアナノテクノロジー市場セグメンテーション

  • 世界のヘルスケアナノテクノロジー市場、疾患別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 心血管疾患
  • 腫瘍性疾患
  • 神経疾患
  • 整形外科疾患
  • 感染症
  • 世界のヘルスケアナノテクノロジー市場、タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • オーガニック
  • 無機
  • カーボンベース
  • 世界のヘルスケアナノテクノロジー市場、アプリケーション別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • ドラッグデリバリー
  • 生体材料
  • アクティブインプラント
  • 組織の再生

第7章 ヘルスケアナノテクノロジー市場の地域および国分析

  • 世界のヘルスケアナノテクノロジー市場、地域別、実績および予測、2018-2023、2023-2028F、2033F
  • 世界のヘルスケアナノテクノロジー市場、国別、実績および予測、2018-2023、2023-2028F、2033F

第8章 アジア太平洋のヘルスケアナノテクノロジー市場

  • 概要
  • 地域情報、COVID-19の影響、市場情報、背景情報、政府の取り組み、規制、規制機関、主要団体、課税額、法人税構造、投資、主要企業
  • 疾患別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • アジア太平洋のヘルスケアナノテクノロジー市場、アプリケーション別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第9章 中国のヘルスケアナノテクノロジー市場

第10章 インドのヘルスケアナノテクノロジー市場

第11章 日本のヘルスケアナノテクノロジー市場

第12章 オーストラリアのヘルスケアナノテクノロジー市場

第13章 インドネシアのヘルスケアナノテクノロジー市場

第14章 韓国のヘルスケアナノテクノロジー市場

第15章 西欧のヘルスケアナノテクノロジー市場

  • 概要
  • 疾患別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 西欧のヘルスケアナノテクノロジー市場、アプリケーション別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第16章 英国のヘルスケアナノテクノロジー市場

第17章 ドイツのヘルスケアナノテクノロジー市場

第18章 フランスのヘルスケアナノテクノロジー市場

第19章 イタリアのヘルスケアナノテクノロジー市場

第20章 スペインのヘルスケアナノテクノロジー市場

第21章 東欧のヘルスケアナノテクノロジー市場

  • 概要
  • 疾患別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 東欧のヘルスケアナノテクノロジー市場、アプリケーション別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第22章 ロシアのヘルスケアナノテクノロジー市場

第23章 北米のヘルスケアナノテクノロジー市場

  • 概要
  • 疾患別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 北米のヘルスケアナノテクノロジー市場、アプリケーション別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第24章 米国のヘルスケアナノテクノロジー市場

第25章 カナダのヘルスケアナノテクノロジー市場

第26章 南米のヘルスケアナノテクノロジー市場

  • 概要
  • 疾患別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 南米のヘルスケアナノテクノロジー市場、アプリケーション別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第27章 ブラジルのヘルスケアナノテクノロジー市場

第28章 中東のヘルスケアナノテクノロジー市場

  • 概要
  • 疾患別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 中東のヘルスケアナノテクノロジー市場、アプリケーション別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第29章 アフリカのヘルスケアナノテクノロジー市場

  • 概要
  • 疾患別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • アフリカのヘルスケアナノテクノロジー市場、アプリケーション別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第30章 ヘルスケアナノテクノロジー市場の競合情勢と企業プロファイル

  • ヘルスケアナノテクノロジー市場の競合情勢
  • ヘルスケアナノテクノロジー市場の企業プロファイル
    • Pfizer Inc.
      • 財務実績
    • Johnson &Johnson Inc.
      • 財務実績
    • Abbott Laboratories
      • 財務実績
    • Celgene Corporation
      • 1.概要
      • 2.製品とサービス
      • 3.戦略
      • 4.財務実績
    • Merck & Company Inc
      • 1.概要
      • 2.製品とサービス
      • 3.戦略
      • 4.財務実績

第31章 世界のヘルスケアナノテクノロジー市場の競合ベンチマーキング

第32章 世界のヘルスケアナノテクノロジー市場競争ダッシュボード

第33章 ヘルスケアナノテクノロジー市場における主要な合併と買収

第34章 ヘルスケアナノテクノロジー市場の将来展望と潜在力分析

第35章 付録

目次
Product Code: r10381

“Healthcare Nanotechnology Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on healthcare nanotechnology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for healthcare nanotechnology? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The healthcare nanotechnology market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Disease: Cardiovascular Diseases; Oncological Diseases; Neurological Diseases; Orthopedic Diseases; Infectious Diseases
  • 2) By Type: Organic; Inorganic; Carbon-Based
  • 3) By Application: Drug Delivery; Biomaterials; Active Implants; Tissue Regeneration
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Inc.; Abbott Laboratories; Celgene Corporation; Merck & Company Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Healthcare nanotechnology refers to the area of science that combines nanotechnology with drugs or diagnostic molecules to improve the performance of specific cells or tissues. These materials are produced on a nanoscale level and are safe to inject into the body. Nanotechnologies can greatly enhance medical diagnostics by making them more affordable and practical.

The main types of healthcare nanotechnology include organic, inorganic, and carbon-based. Healthcare nanotechnology is used for various diseases such as cardiovascular, oncological, neurological, orthopedic, and infectious diseases. The main applications of healthcare nanotechnology include drug delivery, biomaterials, active implants, and tissue regeneration.

The healthcare nanotechnology market research report is one of a series of new reports from The Business Research Company that provides healthcare nanotechnology market statistics, including healthcare nanotechnology industry global market size, regional shares, competitors with healthcare nanotechnology market share, detailed healthcare nanotechnology market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare nanotechnology industry. This healthcare nanotechnology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The healthcare nanotechnology market size has grown rapidly in recent years. It will grow from $308. 03 billion in 2023 to $351. 82 billion in 2024 at a compound annual growth rate (CAGR) of 14. 2%. The growth in the historic period can be attributed to advancements in nanomaterials, nanomedicine research, regulatory support, investment in research and development, nanostructured biomaterials.

The healthcare nanotechnology market size is expected to see rapid growth in the next few years. It will grow to $613. 9 billion in 2028 at a compound annual growth rate (CAGR) of 14. 9%. The growth in the forecast period can be attributed to theranostics development, nanoparticles for gene therapy, biocompatible nanomaterials, nano-enabled surgical tools, nanoscale therapeutic agents, global health emergency preparedness. . Major trends in the forecast period include diagnostic nanodevices, biosensors and imaging, nanorobotics and nanosurgery, personalized medicine, public awareness and educationtherapeutic applications. .

Increasing cancer disease cases are expected to propel the growth of the healthcare nanotechnology market. Nanotechnology is a promising mode of cancer treatment. This improving field of medical research can be used to discover better personalized treatments for many diseases, including cancer. Globally, the prevalence of cancer is increasing. For instance, in January 2021, according to the National Library of Medicine the United States is projected to have 1,898,160 new cancer cases and 608,570 cancer deaths in 2021 . Therefore, the increasing number of cancer disease cases is driving the healthcare nanotechnology market growth.

Growing incidences of diabetes and obesity are expected to propel the growth of the healthcare nanotechnology market going forward. Diabetes refers to a condition that develops when blood glucose levels are too high, and obesity refers to the condition of having a body mass index of 30 or more. Healthcare nanotechnology offers targeted drug delivery and precision medicine approaches to manage diabetes and obesity, improving treatment efficacy while minimizing side effects. For instance, in June 2022, according to the International Diabetes Federation, a Belgium-based diabetes federation, the prevalence of diabetes had increased to 10. 5% worldwide, with over half (44. 7%) of people still undiagnosed. According to IDF predictions, 783 million adults, or one in eight people, will have diabetes by 2045. This would represent a 46% rise, more than double the projected population growth for the same period (20%). Furthermore, in March 2022, according to the World Health Organization, a Switzerland-based agency, 650 million adults, 340 million teenagers, and 39 million children will be obese. This quantity is still rising, and the WHO predicts that by 2025, 167 million adults and children will become overweight or obese. Therefore, growing incidences of diabetes and obesity are driving the growth of the healthcare nanotechnology market.

Strategic collaboration between companies is a key trend gaining popularity in the healthcare nanotechnology market. Companies involved in healthcare nanotechnologies are undergoing partnerships and collaboration to develop new technologies and products. In January 2022, NaNotics, a US-based medical company, collaborated with the Mayo Clinic to develop a cancer treatment known as NaNots. The collaboration will involve NaNotics sharing its nano-depletion platform with Mayo researchers, while the Mayo Clinic will provide its own PD-L1 antibody and a transgenic mouse model that provides human sPD-L1. Mayo Clinic is a US-based clinic dedicated to providing patient care, education, and research in various fields of medicine, including nanomedicine.

Major companies operating in the healthcare nanotechnology market are increasing their focus on introducing nanotechnology-based gel serums to gain a competitive edge in the market. Nanotechnology-based gel serums are products that incorporate nanoscale particles or delivery systems to enhance the absorption and effectiveness of active ingredients. For instance, in March 2023, ENTOD Pharmaceuticals, an India-based healthcare company, launched Eyecirque, a nanotechnology-based under-eye product, in India. Eyecirque is formulated with a cutting-edge, 100% plant-based biocellular composition, featuring vitamin A, C, and E complexes, anti-aging antioxidants, skin-brightening agents, and naturally occurring ultra-moisturizing elements that are rapidly absorbed into the skin around the eyes at a nano-molecular level. It stands as the world's first gel serum of its kind, utilizing nanotechnology to address concerns such as wrinkles, hollowness, hollow eyelids, and dark circles under the eyes.

In July 2021, Fortis Life Sciences, a US-based healthcare company, acquired NanoComposix Inc. for an undisclosed amount. The acquisition is expected to enhance Fortis Life Sciences capabilities, bring new expertise, and broaden its product portfolio within nanomaterials and diagnostics. NanoComposix Inc. is a US-based company that specializes in developing innovative nanomaterials for research and commercial markets.

Major companies operating in the in the healthcare nanotechnology market report are Pfizer Inc., Johnson & Johnson Inc., Abbott Laboratories, Celgene Corporation, Merck & Company Inc., Union Chimique Belge S. A, Teva Pharmaceutical Industries Ltd., Sanofi SA, Taiwan Liposome Company Ltd., GE Healthcare Technologies Inc., Mallinckrodt plc, Leadiant Biosciences, Luminex Corporation, Bristol-Myers Squibb Company, CytImmune Sciences Inc., Nanobiotix, Starpharma Holdings Limited, Copernicus Therapeutics Inc., NanoCarrier Co. Ltd, Ensysce Biosciences Inc., Ocuphire Pharma Inc., LiPlasome Pharma ApS, Nami Therapeutics Corp., Nanospectra Biosciences Inc., Genetic Immunity Inc., Spago Nanomedical AB, Nanobiosym Inc., Nanopoint Inc., Nanosphere Health Sciences Inc., Nanoviricides Inc., Nanotherapeutics Inc., Nanosyn Inc., Nanoscale Corporation, Nanosys Inc., Nanocarrier Co. Ltd., Nanocor Therapeutics Inc., Nanocyl SA, Nanogen Pvt. Ltd.

North America was the largest region in the healthcare nanotechnology market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare nanotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the healthcare nanotechnology market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The healthcare nanotechnology market includes revenues earned by entities by targeting tumors, in drug delivery systems, and improving medical imaging. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified)).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Healthcare Nanotechnology Market Characteristics

3. Healthcare Nanotechnology Market Trends And Strategies

4. Healthcare Nanotechnology Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Healthcare Nanotechnology Market Size and Growth

  • 5.1. Global Healthcare Nanotechnology Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Healthcare Nanotechnology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Healthcare Nanotechnology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Healthcare Nanotechnology Market Segmentation

  • 6.1. Global Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cardiovascular Diseases
  • Oncological Diseases
  • Neurological Diseases
  • Orthopedic Diseases
  • Infectious Diseases
  • 6.2. Global Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Organic
  • Inorganic
  • Carbon-Based
  • 6.3. Global Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drug Delivery
  • Biomaterials
  • Active Implants
  • Tissue Regeneration

7. Healthcare Nanotechnology Market Regional And Country Analysis

  • 7.1. Global Healthcare Nanotechnology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Healthcare Nanotechnology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Healthcare Nanotechnology Market

  • 8.1. Asia-Pacific Healthcare Nanotechnology Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8. 4. Asia-Pacific Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Healthcare Nanotechnology Market

  • 9.1. China Healthcare Nanotechnology Market Overview
  • 9.2. China Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9. 4. China Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Healthcare Nanotechnology Market

  • 10.1. India Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Healthcare Nanotechnology Market

  • 11.1. Japan Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Healthcare Nanotechnology Market

  • 12.1. Australia Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Healthcare Nanotechnology Market

  • 13.1. Indonesia Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Healthcare Nanotechnology Market

  • 14.1. South Korea Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Healthcare Nanotechnology Market

  • 15.1. Western Europe Healthcare Nanotechnology Market Overview
  • 15.2. Western Europe Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15. 4. Western Europe Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Healthcare Nanotechnology Market

  • 16.1. UK Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Healthcare Nanotechnology Market

  • 17.1. Germany Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Healthcare Nanotechnology Market

  • 18. 5. France Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18. 6. France Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18. 7. France Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Healthcare Nanotechnology Market

  • 19. 9. Italy Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Healthcare Nanotechnology Market

  • 20.13. Spain Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Healthcare Nanotechnology Market

  • 21.1. Eastern Europe Healthcare Nanotechnology Market Overview
  • 21.2. Eastern Europe Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21. 4. Eastern Europe Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Healthcare Nanotechnology Market

  • 22.1. Russia Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Healthcare Nanotechnology Market

  • 23.1. North America Healthcare Nanotechnology Market Overview
  • 23.2. North America Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23. 4. North America Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Healthcare Nanotechnology Market

  • 24.1. USA Healthcare Nanotechnology Market Overview
  • 24.2. USA Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24. 4. USA Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Healthcare Nanotechnology Market

  • 25.1. Canada Healthcare Nanotechnology Market Overview
  • 25.2. Canada Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25. 4. Canada Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Healthcare Nanotechnology Market

  • 26.1. South America Healthcare Nanotechnology Market Overview
  • 26.2. South America Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26. 4. South America Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Healthcare Nanotechnology Market

  • 27.1. Brazil Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Healthcare Nanotechnology Market

  • 28.1. Middle East Healthcare Nanotechnology Market Overview
  • 28.2. Middle East Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28. 4. Middle East Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Healthcare Nanotechnology Market

  • 29.1. Africa Healthcare Nanotechnology Market Overview
  • 29.2. Africa Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29. 4. Africa Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Healthcare Nanotechnology Market Competitive Landscape And Company Profiles

  • 30.1. Healthcare Nanotechnology Market Competitive Landscape
  • 30.2. Healthcare Nanotechnology Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1. 4. Financial Performance
    • 30.2.2. Johnson & Johnson Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2. 4. Financial Performance
    • 30.2.3. Abbott Laboratories
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3. 4. Financial Performance
    • 30.2. 4. Celgene Corporation
      • 30.2. 4.1. Overview
      • 30.2. 4.2. Products and Services
      • 30.2. 4.3. Strategy
      • 30.2. 4. 4. Financial Performance
    • 30.2. 5. Merck & Company Inc
      • 30.2. 5.1. Overview
      • 30.2. 5.2. Products and Services
      • 30.2. 5.3. Strategy
      • 30.2. 5. 4. Financial Performance

31. Global Healthcare Nanotechnology Market Competitive Benchmarking

32. Global Healthcare Nanotechnology Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Healthcare Nanotechnology Market

34. Healthcare Nanotechnology Market Future Outlook and Potential Analysis

  • 34.1 Healthcare Nanotechnology Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Healthcare Nanotechnology Market In 2028 - Segments Offering Most New Opportunities
  • 34. 3 Healthcare Nanotechnology Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35. 4. Research Inquiries
  • 35. 5. The Business Research Company
  • 35. 6. Copyright And Disclaimer